Biogen Inc (BIIB)
190.45
-1.71
(-0.89%)
USD |
NASDAQ |
Apr 18, 16:00
190.55
+0.10
(+0.05%)
Pre-Market: 08:40
Biogen Cash and Short Term Investments (Quarterly): 1.050B for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.050B |
| September 30, 2023 | 2.288B |
| June 30, 2023 | 6.078B |
| March 31, 2023 | 5.041B |
| December 31, 2022 | 4.893B |
| September 30, 2022 | 4.911B |
| June 30, 2022 | 4.798B |
| March 31, 2022 | 3.752B |
| December 31, 2021 | 3.802B |
| September 30, 2021 | 2.955B |
| June 30, 2021 | 3.051B |
| March 31, 2021 | 2.538B |
| December 31, 2020 | 2.610B |
| September 30, 2020 | 3.580B |
| June 30, 2020 | 4.328B |
| March 31, 2020 | 3.860B |
| December 31, 2019 | 4.476B |
| September 30, 2019 | 4.437B |
| June 30, 2019 | 2.952B |
| March 31, 2019 | 3.909B |
| December 31, 2018 | 3.538B |
| September 30, 2018 | 4.428B |
| June 30, 2018 | 3.224B |
| March 31, 2018 | 5.916B |
| December 31, 2017 | 3.689B |
| Date | Value |
|---|---|
| September 30, 2017 | 3.508B |
| June 30, 2017 | 2.893B |
| March 31, 2017 | 2.880B |
| December 31, 2016 | 4.895B |
| September 30, 2016 | 4.316B |
| June 30, 2016 | 3.797B |
| March 31, 2016 | 3.585B |
| December 31, 2015 | 3.428B |
| September 30, 2015 | 5.843B |
| June 30, 2015 | 2.369B |
| March 31, 2015 | 2.152B |
| December 31, 2014 | 1.845B |
| September 30, 2014 | 1.861B |
| June 30, 2014 | 1.573B |
| March 31, 2014 | 1.260B |
| December 31, 2013 | 1.223B |
| September 30, 2013 | 668.69M |
| June 30, 2013 | 667.67M |
| March 31, 2013 | 3.631B |
| December 31, 2012 | 1.706B |
| September 30, 2012 | 1.606B |
| June 30, 2012 | 1.406B |
| March 31, 2012 | 1.277B |
| December 31, 2011 | 1.691B |
| September 30, 2011 | 1.520B |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
1.050B
Minimum
Dec 2023
6.078B
Maximum
Jun 2023
3.758B
Average
3.802B
Median
Dec 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| Eli Lilly and Co | 2.928B |
| Bristol-Myers Squibb Co | 12.28B |
| AbbVie Inc | 12.82B |
| Amgen Inc | 10.94B |
| Regeneron Pharmaceuticals Inc | 10.84B |